organophosphonates has been researched along with Fasting Hypoglycemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrish, JC; Behnia, K; Bolton, S; Brigance, RP; Cap, M; Chen, BC; Chen, S; Chen, XQ; Cheng, PTW; Ellsworth, B; Everlof, G; Fuentes-Catanio, HG; Fura, A; Griffen, S; Gupta, A; Janovitz, EB; Jones, B; Kalinowski, S; Kirby, M; Kopcho, L; Krupinski, J; Krystek, SR; Kunselman, L; Langish, RA; Leith, LW; Li, YX; Liu, H; Ma, X; Marcinkeviciene, J; Mathur, A; Meng, W; Muckelbauer, JK; Nielsen, L; O'Malley, K; Pannacciulli, N; Rampulla, R; Robl, JA; Ryono, DE; Shi, Y; Smirk, R; Spronk, SA; Staal, A; Sulsky, R; Sun, D; Sun, JH; Swartz, J; Tao, S; Taylor, JR; Tino, JA; Wang, A; Wang, Q; Wang, Y; Whaley, J; Williams, KN; Wong, MKY; Wu, DR; Xu, C; Yang, Y; Zahler, R; Zalaznick, J; Zebo, R; Zhang, H; Zinker, BA | 1 |
1 other study(ies) available for organophosphonates and Fasting Hypoglycemia
| Article | Year |
|---|---|
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1
Topics: Azetidines; Diabetes Mellitus, Type 2; Glucokinase; Humans; Hypoglycemia; Hypoglycemic Agents; Organophosphonates | 2022 |